EfficacyPhaseIVDropoutRateSourceDataVerificationProtocolInvestigatorMeetingFollow-up VisitGoodClinicalPractice(GCP)PilotStudyEndpointTrialMonitorDataManagementAdverseEventData SafetyMonitoringBoard(DSMB)ProtocolDeviationClinicalResearchCoordinatorPhaseIIIInstitutionalReviewBoard(IRB)ParallelStudyInformedConsentClinicalEndpointControlGroupClinicalStudyReport(CSR)InterventionDataLockPhaseIAdaptiveDesignCaseReportForm(CRF)TrialRegistryDouble-BlindStudyEligibilityCriteriaBlindingPhaseIISafetyProfileAuditTrailStatisticalAnalysisPlan(SAP)RegulatoryAuthorityOpen-LabelTrialScreeningVisitRandomizationSurrogateEndpointRecruitmentTargetPrincipalInvestigatorStandardOperatingProcedure(SOP)CrossoverStudyMulticenterTrialSponsorEthicsCommitteePatientRecruitmentPlaceboEfficacyPhaseIVDropoutRateSourceDataVerificationProtocolInvestigatorMeetingFollow-up VisitGoodClinicalPractice(GCP)PilotStudyEndpointTrialMonitorDataManagementAdverseEventData SafetyMonitoringBoard(DSMB)ProtocolDeviationClinicalResearchCoordinatorPhaseIIIInstitutionalReviewBoard(IRB)ParallelStudyInformedConsentClinicalEndpointControlGroupClinicalStudyReport(CSR)InterventionDataLockPhaseIAdaptiveDesignCaseReportForm(CRF)TrialRegistryDouble-BlindStudyEligibilityCriteriaBlindingPhaseIISafetyProfileAuditTrailStatisticalAnalysisPlan(SAP)RegulatoryAuthorityOpen-LabelTrialScreeningVisitRandomizationSurrogateEndpointRecruitmentTargetPrincipalInvestigatorStandardOperatingProcedure(SOP)CrossoverStudyMulticenterTrialSponsorEthicsCommitteePatientRecruitmentPlacebo

Clinical Trials Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
  1. Efficacy
  2. Phase IV
  3. Dropout Rate
  4. Source Data Verification
  5. Protocol
  6. Investigator Meeting
  7. Follow-up Visit
  8. Good Clinical Practice (GCP)
  9. Pilot Study
  10. Endpoint
  11. Trial Monitor
  12. Data Management
  13. Adverse Event
  14. Data Safety Monitoring Board (DSMB)
  15. Protocol Deviation
  16. Clinical Research Coordinator
  17. Phase III
  18. Institutional Review Board (IRB)
  19. Parallel Study
  20. Informed Consent
  21. Clinical Endpoint
  22. Control Group
  23. Clinical Study Report (CSR)
  24. Intervention
  25. Data Lock
  26. Phase I
  27. Adaptive Design
  28. Case Report Form (CRF)
  29. Trial Registry
  30. Double-Blind Study
  31. Eligibility Criteria
  32. Blinding
  33. Phase II
  34. Safety Profile
  35. Audit Trail
  36. Statistical Analysis Plan (SAP)
  37. Regulatory Authority
  38. Open-Label Trial
  39. Screening Visit
  40. Randomization
  41. Surrogate Endpoint
  42. Recruitment Target
  43. Principal Investigator
  44. Standard Operating Procedure (SOP)
  45. Crossover Study
  46. Multicenter Trial
  47. Sponsor
  48. Ethics Committee
  49. Patient Recruitment
  50. Placebo